ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 1121

$555K Total Retail Price of All Prescriptions

Rank: 341 out of 1121

446 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,911 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 361 273 S3 1 3
LEVOTHYROXINE SODIUM 359 314 2 2
SIMVASTATIN 343 309 3 1
OMEPRAZOLE 340 303 4 6
LISINOPRIL 300 279 5 4
FUROSEMIDE 218 202 6 7
WARFARIN SODIUM 172 170 7 11
TAMSULOSIN HCL 169 149 8 32
ZOLPIDEM TARTRATE 167 147 9 19
AMLODIPINE BESYLATE 158 150 10 5
METFORMIN HCL 150 132 11 8
TRAMADOL HCL 148 135 12 25
HYDROCHLOROTHIAZIDE 144 142 13 10
METOPROLOL TARTRATE 142 139 14 9
MIRTAZAPINE 134 132 15 56
POTASSIUM CHLORIDE 132 130 16 12
GABAPENTIN 123 115 17 13
SERTRALINE HCL 122 122 18 21
DONEPEZIL HCL 118 118 19 35
PRAVASTATIN SODIUM 117 109 20 14
TRAZODONE HCL 105 92 21 40
LOSARTAN POTASSIUM 104 97 22 17
BENAZEPRIL HCL 103 95 23 41
ATENOLOL 96 78 24 16
MELOXICAM 96 73 24 22
CITALOPRAM HBR 93 89 26 18
FLUOXETINE HCL 91 73 27 60
EXELON 88 88 28 119
NAMENDA 88 88 28 53
METOPROLOL SUCCINATE 84 81 30 23
FLUTICASONE PROPIONATE 83 81 31 36
PREDNISONE 82 63 32 43
DIVALPROEX SODIUM 81 79 33 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 61 34 31
ROPINIROLE HCL 75 70 34 91
ATORVASTATIN CALCIUM 75 73 34 15
DOXYCYCLINE HYCLATE 71 59 37 103
GLYBURIDE 68 64 R 38 51
RANITIDINE HCL 63 62 39 33
CALCITRIOL 63 63 39 272
NEXIUM 62 43 41 24
OXYCODONE HCL-ACETAMINOPHEN 60 23 S2 42 86
CLONIDINE HCL 60 56 42 39
CLOPIDOGREL 56 53 44 27
TRIAMTERENE-HCTZ 56 53 44 38
DILTIAZEM 24HR CD 54 54 46 99
ALLOPURINOL 54 53 46 30
PAROXETINE HCL 52 39 48 58
CYMBALTA 52 52 48 50
NYSTATIN 50 50 50 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.